GDOC
Exchange-traded product on NYSE (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Aug 31, 2026
The full portfolio as of the quarter end Aug 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Oct 27, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of May 31, 2026.
41 lines, 38 linked, weights sum to 100.41% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| ELI LILLY & COMPANY | LLY US5324571083 | Equity | 2,066 | −351 | 12.19% | $ 2.39M |
| JOHNSON & JOHNSON | JNJ US4781601046 | Equity | 6,127 | −1,077 | 8.31% | $ 1.629M |
| MERCK & COMPANY INC | MRK US58933Y1055 | Equity | 9,861 | −212 | 7.44% | $ 1.457M |
| UNITEDHEALTH GROUP INC | UNH US91324P1021 | Equity | 2,912 | +2,197 | 5.79% | $ 1.134M |
| VERTEX PHARMACEUTICALS INC | VRTX US92532F1003 | Equity | 1,511 | +844 | 4.20% | $ 822.77K |
| ARGENX SE | ARGX US04016X1019 | Equity | 787 | −192 | 4.14% | $ 811.916K |
| GUARDANT HEALTH INC | GH US40131M1099 | Equity | 4,952 | −3,334 | 4.02% | $ 787.467K |
| DEXCOM INC | DXCM US2521311074 | Equity | 8,317 | +696 | 3.86% | $ 757.346K |
| AGILENT TECHNOLOGIES INC | A US00846U1016 | Equity | 4,485 | +380 | 3.51% | $ 688.717K |
| THERMO FISHER SCIENTIFIC INC | TMO US8835561023 | Equity | 1,114 | −733 | 3.51% | $ 687.449K |
| EDWARDS LIFESCIENCES CORP | EW US28176E1082 | Equity | 7,509 | +570 | 3.48% | $ 681.442K |
| INTUITIVE SURGICAL INC | ISRG US46120E6023 | Equity | 1,526 | −323 | 2.93% | $ 575.088K |
| LONZA GROUP AG | LONN CH0013841017 | Equity | 771 | −108 | 2.81% | $ 550.23K |
| CENCORA INC | COR US03073E1055 | Equity | 1,619 | −131 | 2.67% | $ 523.908K |
| ROIVANT SCIENCES LTD | ROIV BMG762791017 | Equity | 14,044 | −1,992 | 2.48% | $ 486.484K |
| HOYA CORP | 7741 JP3837800006 | Equity | 2,595 | −1,578 | 2.04% | $ 399.743K |
| ASTRAZENECA PLC | AZN GB0009895292 | Equity | 2,440 | −2,794 | 2.02% | $ 395.986K |
| ROYALTY PHARMA PLC | RPRX GB00BMVP7Y09 | Equity | 5,584 | −786 | 1.75% | $ 342.913K |
| METTLER-TOLEDO INTERNATIONAL INC | MTD US5926881054 | Equity | 238 | −33 | 1.71% | $ 334.423K |
| REPLIGEN CORP | RGEN US7599161095 | Equity | 1,789 | −249 | 1.65% | $ 323.773K |
|
Goldman Sachs Trust
|
FTOXX US38141W3236 | Money market | 311,849.22 | +23,860.64 | 1.59% | $ 311.849K |
| CYTOKINETICS INC | CYTK US23282W6057 | Equity | 4,355 | +692 | 1.58% | $ 308.813K |
| NATERA INC | NTRA US6323071042 | Equity | 955 | new +955 | 1.57% | $ 307.472K |
| BOSTON SCIENTIFIC CORP | BSX US1011371077 | Equity | 6,257 | −9,483 | 1.54% | $ 302.213K |
|
GALDERMA GROUP AG
|
GALD CH1335392721 | Equity | 1,318 | +284 | 1.40% | $ 273.893K |
| QUEST DIAGNOSTICS INC | DGX US74834L1008 | Equity | 1,125 | +384 | 1.38% | $ 270.338K |
| INSMED INC | INSM US4576693075 | Equity | 1,823 | −258 | 1.13% | $ 222.078K |
| MADRIGAL PHARMACEUTICALS INC | MDGL US5588681057 | Equity | 376 | −54 | 1.04% | $ 203.051K |
| DIANTHUS THERAPEUTICS INC | DNTH US2528281080 | Equity | 1,761 | new +1,761 | 0.95% | $ 185.979K |
| BRIDGEBIO PHARMA INC | BBIO US10806X1028 | Equity | 2,421 | +207 | 0.95% | $ 185.424K |
| XENON PHARMACEUTICALS INC | XENE CA98420N1050 | Equity | 2,974 | −2,003 | 0.91% | $ 179.094K |
| SPYRE THERAPEUTICS INC | SYRE US00773J2024 | Equity | 1,690 | +730 | 0.77% | $ 150.968K |
| DEFINIUM THERAPEUTICS INC | DFTX CA24477V1058 | Equity | 3,695 | −519 | 0.75% | $ 146.765K |
| RHYTHM PHARMACEUTICALS INC | RYTM US76243J1051 | Equity | 1,346 | −192 | 0.73% | $ 142.851K |
| PRAXIS PRECISION MEDICINES INC | PRAX US74006W2070 | Equity | 406 | +90 | 0.73% | $ 142.222K |
| ALKERMES PLC | ALKS IE00B56GVS15 | Equity | 2,367 | −336 | 0.57% | $ 111.225K |
| SARTORIUS STEDIM BIOTECH SA | DIM FR0013154002 | Equity | 467 | −66 | 0.54% | $ 106.324K |
| KARDIGAN INC | KARD US4859251013 | Equity | 4,775 | new +4,775 | 0.49% | $ 96.264K |
|
GOLDMAN SACHS FINANCIAL SQUARE FUNDS PRIME OBLIGATIONS FUND
|
FGTXX | Money market | 94,704.09 | new +94,704.09 | 0.48% | $ 94.704K |
| STRUCTURE THERAPEUTICS INC | GPCR US86366E1064 | Equity | 1,838 | +830 | 0.43% | $ 84.383K |
| CG ONCOLOGY INC | CGON US1569441009 | Equity | 960 | −1,472 | 0.37% | $ 72.154K |